Literature DB >> 25670329

Cellular origin of prognostic chromosomal aberrations in AML patients.

H Mora-Jensen1, J Jendholm2, N Rapin3, M K Andersen4, A S Roug5, F O Bagger3, L Bullinger6, O Winther7, N Borregaard1, B T Porse2, K Theilgaard-Mönch8.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25670329     DOI： 10.1038/leu.2015.30

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  15 in total

1.  A conceptual framework for the identification of candidate drugs and drug targets in acute promyelocytic leukemia.

Authors:  T T Marstrand; R Borup; A Willer; N Borregaard; A Sandelin; B T Porse; K Theilgaard-Mönch
Journal:  Leukemia       Date:  2010-05-27       Impact factor: 11.528

2.  Genomic landscapes and clonality of de novo AML.

Authors:  Christopher A Miller; Richard K Wilson; Timothy J Ley
Journal:  N Engl J Med       Date:  2013-10-10       Impact factor: 91.245

3.  Cell of origin determines clinically relevant subtypes of MLL-rearranged AML.

Authors:  A V Krivtsov; M E Figueroa; A U Sinha; M C Stubbs; Z Feng; P J M Valk; R Delwel; K Döhner; L Bullinger; A L Kung; A M Melnick; S A Armstrong
Journal:  Leukemia       Date:  2012-12-13       Impact factor: 11.528

4.  Clonal evolution of preleukemic hematopoietic stem cells precedes human acute myeloid leukemia.

Authors:  Max Jan; Thomas M Snyder; M Ryan Corces-Zimmerman; Paresh Vyas; Irving L Weissman; Stephen R Quake; Ravindra Majeti
Journal:  Sci Transl Med       Date:  2012-08-29       Impact factor: 17.956

5.  The origin and evolution of mutations in acute myeloid leukemia.

Authors:  John S Welch; Timothy J Ley; Daniel C Link; Christopher A Miller; David E Larson; Daniel C Koboldt; Lukas D Wartman; Tamara L Lamprecht; Fulu Liu; Jun Xia; Cyriac Kandoth; Robert S Fulton; Michael D McLellan; David J Dooling; John W Wallis; Ken Chen; Christopher C Harris; Heather K Schmidt; Joelle M Kalicki-Veizer; Charles Lu; Qunyuan Zhang; Ling Lin; Michelle D O'Laughlin; Joshua F McMichael; Kim D Delehaunty; Lucinda A Fulton; Vincent J Magrini; Sean D McGrath; Ryan T Demeter; Tammi L Vickery; Jasreet Hundal; Lisa L Cook; Gary W Swift; Jerry P Reed; Patricia A Alldredge; Todd N Wylie; Jason R Walker; Mark A Watson; Sharon E Heath; William D Shannon; Nobish Varghese; Rakesh Nagarajan; Jacqueline E Payton; Jack D Baty; Shashikant Kulkarni; Jeffery M Klco; Michael H Tomasson; Peter Westervelt; Matthew J Walter; Timothy A Graubert; John F DiPersio; Li Ding; Elaine R Mardis; Richard K Wilson
Journal:  Cell       Date:  2012-07-20       Impact factor: 41.582

6.  Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials.

Authors:  David Grimwade; Robert K Hills; Anthony V Moorman; Helen Walker; Stephen Chatters; Anthony H Goldstone; Keith Wheatley; Christine J Harrison; Alan K Burnett
Journal:  Blood       Date:  2010-04-12       Impact factor: 22.113

7.  Chromatin organization is a major influence on regional mutation rates in human cancer cells.

Authors:  Benjamin Schuster-Böckler; Ben Lehner
Journal:  Nature       Date:  2012-08-23       Impact factor: 49.962

8.  Preleukemic mutations in human acute myeloid leukemia affect epigenetic regulators and persist in remission.

Authors:  M Ryan Corces-Zimmerman; Wan-Jen Hong; Irving L Weissman; Bruno C Medeiros; Ravindra Majeti
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-03       Impact factor: 11.205

Review 9.  Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet.

Authors:  Hartmut Döhner; Elihu H Estey; Sergio Amadori; Frederick R Appelbaum; Thomas Büchner; Alan K Burnett; Hervé Dombret; Pierre Fenaux; David Grimwade; Richard A Larson; Francesco Lo-Coco; Tomoki Naoe; Dietger Niederwieser; Gert J Ossenkoppele; Miguel A Sanz; Jorge Sierra; Martin S Tallman; Bob Löwenberg; Clara D Bloomfield
Journal:  Blood       Date:  2009-10-30       Impact factor: 22.113

10.  Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing.

Authors:  Li Ding; Timothy J Ley; David E Larson; Christopher A Miller; Daniel C Koboldt; John S Welch; Julie K Ritchey; Margaret A Young; Tamara Lamprecht; Michael D McLellan; Joshua F McMichael; John W Wallis; Charles Lu; Dong Shen; Christopher C Harris; David J Dooling; Robert S Fulton; Lucinda L Fulton; Ken Chen; Heather Schmidt; Joelle Kalicki-Veizer; Vincent J Magrini; Lisa Cook; Sean D McGrath; Tammi L Vickery; Michael C Wendl; Sharon Heath; Mark A Watson; Daniel C Link; Michael H Tomasson; William D Shannon; Jacqueline E Payton; Shashikant Kulkarni; Peter Westervelt; Matthew J Walter; Timothy A Graubert; Elaine R Mardis; Richard K Wilson; John F DiPersio
Journal:  Nature       Date:  2012-01-11       Impact factor: 49.962
View more
  6 in total

1.  Human adult HSCs can be discriminated from lineage-committed HPCs by the expression of endomucin.

Authors:  Kristian Reckzeh; Hüsün Kizilkaya; Alexandra Søgaard Helbo; Montserrat Estruch Alrich; André Gundersen Deslauriers; Amit Grover; Nicolas Rapin; Fazila Asmar; Kirsten Grønbæk; Bo Porse; Niels Borregaard; Dietmar Vestweber; Claus Nerlov; Kim Theilgaard-Mönch
Journal:  Blood Adv       Date:  2018-07-10

2.  Targeted inhibition of cooperative mutation- and therapy-induced AKT activation in AML effectively enhances response to chemotherapy.

Authors:  Montserrat Estruch; Kristian Reckzeh; Camilla Vittori; Anders Centio; Mina Ali; Sophia Engelhard; Ling Zhao; Kyoung Jae Won; Paul Liu; Bo Torben Porse; Kim Theilgaard-Mönch
Journal:  Leukemia       Date:  2020-12-09       Impact factor: 11.528

3.  Transcription factor-driven coordination of cell cycle exit and lineage-specification in vivo during granulocytic differentiation : In memoriam Professor Niels Borregaard.

Authors:  Kim Theilgaard-Mönch; Sachin Pundhir; Kristian Reckzeh; Jinyu Su; Marta Tapia; Benjamin Furtwängler; Johan Jendholm; Janus Schou Jakobsen; Marie Sigurd Hasemann; Kasper Jermiin Knudsen; Jack Bernard Cowland; Anna Fossum; Erwin Schoof; Mikkel Bruhn Schuster; Bo T Porse
Journal:  Nat Commun       Date:  2022-06-23       Impact factor: 17.694

Review 4.  The multifaceted functions of C/EBPα in normal and malignant haematopoiesis.

Authors:  E Ohlsson; M B Schuster; M Hasemann; B T Porse
Journal:  Leukemia       Date:  2015-11-25       Impact factor: 11.528

5.  Mutant CEBPA directly drives the expression of the targetable tumor-promoting factor CD73 in AML.

Authors:  Janus S Jakobsen; Linea G Laursen; Mikkel B Schuster; Sachin Pundhir; Erwin Schoof; Ying Ge; Teresa d'Altri; Kristoffer Vitting-Seerup; Nicolas Rapin; Coline Gentil; Johan Jendholm; Kim Theilgaard-Mönch; Kristian Reckzeh; Lars Bullinger; Konstanze Döhner; Peter Hokland; Jude Fitzgibbon; Bo T Porse
Journal:  Sci Adv       Date:  2019-07-10       Impact factor: 14.136

6.  Unravelling the relevance of CLEC12A as a cancer stem cell marker in myelodysplastic syndrome.

Authors:  Marie Toft-Petersen; Line Nederby; Eigil Kjeldsen; Gitte B Kerndrup; Gordon D Brown; Peter Hokland; Anne Stidsholt Roug
Journal:  Br J Haematol       Date:  2016-09-09       Impact factor: 6.998
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.